Drug Trial Radar · NCT07219771
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Oct 14, 2025
Primary completion
Jun 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Doron Therapeutics Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Novotech (Australia) Pty Limited
- First posted
- Oct 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, prospective, randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of intra-articular administration of PTP-001 (MOTYS) for the treatment of knee osteoarthritis. The purpose of the trial is to evaluate the efficacy, safety, and tolerability of a single intra-articular injection of PTP-001 compared to placebo over a 52-week period in participants with radiographic and symptomatic knee OA.
Conditions
- Knee Osteoarthritis
Interventions
PTP-01Biological
Allogeneic human placental tissue particulate (PTP-001) is administered as a single intra-articular injection to the target knee after resuspension with saline.
Placebo control / saline vehicleOther
The placebo control, physiological saline (0.9% sodium chloride injection, USP), is administered as an intra-articular injection to the target knee.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants meeting strict responder criteria for improvement in knee function.Time frame: 6 months
- Proportion of participants meeting strict responder criteria for improvement in knee pain.Time frame: 6 months
Locations
18 sites in 2 countries. Site status is shown where the registry gives one.
Central Research Associates, LLC dba Flourish Research
Birmingham, Alabama · Recruiting
Tucson Orthopaedic Institute
Tucson, Arizona · Recruiting
Horizon Clinical Research
La Mesa, California · Recruiting
Focus Clinical Research
West Hills, California · Recruiting
Conquest Research, LLC
Winter Park, Florida · Recruiting
Chicago Clinical Research Institute, Inc.
Chicago, Illinois · Recruiting
Lehigh Center for Clinical Research
Allentown, Pennsylvania · Withdrawn
Coastal Carolina Research Center, LLD
North Charleston, South Carolina · Recruiting
JBR Clinical Research, LLC
Salt Lake City, Utah · Recruiting
Emeritus Research Sydney
Botany, New South Wales, Australia · Terminated
Genesis Research Services
Broadmeadow, New South Wales, Australia · Recruiting
Royal North Shore Hospital
St Leonards, New South Wales, Australia · Active not recruiting
University of the Sunshine Coast Clinical Trials, Birtinya
Birtinya, Queensland, Australia · Active not recruiting
University of the Sunshine Coast Clinical Trials, Maroochydore
Maroochydore, Queensland, Australia · Recruiting
University of the Sunshine Coast Clinical Trials, Morayfield
Morayfield, Queensland, Australia · Active not recruiting
Momentum Clinical Research Taringa
Taringa, Queensland, Australia · Active not recruiting
Momentum Clinical Research Wellers Hill
Tarragindi, Queensland, Australia · Terminated
Momentum Clinical Research Sunshine
St Albans, Victoria, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.